11.   Discovery of the variant genes that promote a disease is a first step to developing drugs that treat its root cause.

12.   Figuring out which genes contribute to disease could help in developing drugs.

13.   Further ahead, lies the possibility of developing drugs to shut telomerase down in the many kinds of cancer cells that activate the gene.

14.   ImmunoGen specializes in developing drugs using monoclonal antibodies that bind to cancer cells.

15.   Many companies are developing drugs that block one or more of the growth factors, hoping to stop the vessels from forming and thereby starving the tumors.

16.   One is Gene Logic, a Gaithersburg, Md., company that provides genomics information to pharmaceutical and biotechnology concerns that are developing drugs.

17.   One area that has been more successful is developing drugs on the farm.

18.   Pfizer, in partnership with Neurogen, is developing drugs that affect GABA receptors.

19.   Scientists now know that nerve cells can regrow and are focusing their attention on developing drugs to prevent the loss of neurons and encourage their regeneration.

20.   Seattle-based Immunex specializes in developing drugs for the immune system.